# Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

> **NCT00770575** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 148 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Pioglitazone and atorvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00770575
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2010-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770575, "Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00770575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*